Entering text into the input field will update the search result below

Regeneron Pharmaceuticals, Inc. (REGN) CEO Leonard Schleifer on Q1 2021 Results - Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts

Call Start: 8:30 January 1, 0000 9:31 AM ET

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Q1 2021 Earnings Conference Call

May 6, 2021 8:30 AM ET

Company Participants

Justin Holko - Vice President, Investor Relations

Leonard Schleifer - Co-Founder, President and Chief Executive Officer

George Yancopoulos - Co-Founder, President and Chief Scientific Officer

Marion McCourt - Senior Vice President, Commercial

Robert Landry - Executive Vice President, Finance and Chief Financial Officer

Conference Call Participants

Terence Flynn - Goldman Sachs

Chris Raymond - Piper Sandler

Cory Kasimov - JPMorgan

Geoffrey Porges - SVB Leerink

Yatin Suneja - Guggenheim Partners

Robyn Karnauskas - Truist Securities

Alethia Young - Cantor Fitzgerald

Mohit Bansal - Citigroup

Yaron Werber - Cowen and Company

Kennen MacKay - RBC Capital Markets

Carter Gould - Barclays


Welcome to the Regeneron Pharmaceuticals First Quarter 2021 Earnings Conference Call. My name is Mary and I will be your operator for today's call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. Please note that this conference is being recorded.

I will now turn the call over to Justin Holko, Vice President, Investor Relations. You may begin.

Justin Holko

Thank you, Mary. Good morning, good afternoon, and good evening to everyone listening around the globe. Thank you for your interest in Regeneron Pharmaceuticals, and welcome to the first quarter 2021 conference call. An archive of this webcast will be available on our website.

Joining me on the call today are Dr. Leonard Schleifer, Founder, President and Chief Executive Officer; Dr. George Yancopoulos, Co-Founder, President and Chief Scientific Officer; Marion McCourt, Executive Vice President and Head of Commercial; Bob Landry, Executive Vice President and Chief Financial Officer. After our prepared remarks, we will open the call for Q&A.

I would also like to remind you

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About REGN

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on REGN

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.